1. Home
  2. LSE vs MNOV Comparison

LSE vs MNOV Comparison

Compare LSE & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$5.00

Market Cap

71.3M

Sector

Industrials

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.35

Market Cap

67.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSE
MNOV
Founded
2007
2000
Country
China
United States
Employees
173
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
67.9M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LSE
MNOV
Price
$5.00
$1.35
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
5.8K
37.0K
Earning Date
01-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,360,807.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$180.00
P/E Ratio
$61.76
N/A
Revenue Growth
N/A
194.15
52 Week Low
$3.20
$1.17
52 Week High
$6.98
$1.96

Technical Indicators

Market Signals
Indicator
LSE
MNOV
Relative Strength Index (RSI) 51.18 47.47
Support Level $4.45 $1.30
Resistance Level $4.98 $1.46
Average True Range (ATR) 0.32 0.04
MACD 0.04 -0.00
Stochastic Oscillator 32.14 33.33

Price Performance

Historical Comparison
LSE
MNOV

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: